Changes
/* Dolcera Dashboard */
'''This is a landscape report on the Ureteral stent market, including key company profiles, products, patents and relevant clinical trailstrials.
'''
=Patents=
==Patent Search Strategy==
[[Image:Patent Search Strategy.jpg|700px]]
'''Dashboard Link'''<br>
{|border="2" cellspacing="0" cellpadding="4" width="100%"
|'''[httphttps://clientwww.dolcera.com/auth/dashboard/dashboard.htmlphp?workfile_id=1008 Ureteral Stent - Dashboard] '''
|width="100"|[[Image:dashboard_thumb.png|center|100px|]]
|-
= Clinical Trials =
==New trials ==
|}
=Products=
The FDA classifies a ureteric stent as follows:
* TITLE 21 - FOOD AND DRUGS
|-
|}
= Product to Clinical Trial Mapping=
= Product to Patent Mapping =
[[Image:Product_Patent_Mapping_Screen_Shot.png|1000px|centre|thumb|'''Screenshot for the product to patent mapping(Bard and Boston)''']]
* Click [[Media:Product_Patent_Mapping_Bard_Boston.xls|'''Products from Boston Scientific and C R Bard ''']]to download the excel file.
=Patent-Product-Clinical Trial Mapping=
* To access the Dashboard you have to signup. You can do so by clicking [https://www.dolcera.com/auth/index.php/login '''here''']
*''Use the mouse(click and drag/scroll up or down/click on nodes) to explore nodes in the detailed taxonomy''
|}
=Insights=
{|border="2" cellspacing="0" cellpadding="4" width="100%"|bgcolor = "#538ED5"|<font size = "4">''' '''</font>|bgcolor = "#538ED5"|<font size = "4">''' '''</font>|bgcolor = "#538ED5"|<font size = "4">'''Boston Scientific'''</font>|bgcolor = "#538ED5"|<font size = "4">'''C R BARD'''</font>|-|align = "center" bgcolor = "#538ED5" rowspan = "4"|'''Products'''|'''Portfolio'''|8 Products|6 Products|-|'''Material'''|Percuflex - Biocompatible Polymer|Silicone|-|'''Coating'''|Hydroplus|Licensed from pHreecoat|-|'''Shape'''|Pigtailed and More|Figure 4 and more|-|align = "center" bgcolor = "#538ED5"|'''Clinical <br>Trials'''|'''Current Trials'''|Truimph Ureteral stent - Loaded with Triclosan <br>Currently in Phase II (Canada)|None|-|align = "center" bgcolor ="#538ED5" rowspan ="3"|'''Patents'''|'''Coating'''|Therapeutic / Medicinal coatings <br>Magnetic nano particles for MRI Imaging <br>Lubricious coatings helping easy insertion|Therapeutic coatings|-|'''Structure'''|Multiple channels filled with therapeutic agent<br>Multiple collapsible segments preventing fluid passing<br>Renal coil with wick to prevent reflux <br>Stent with beads on its surface <br>Stent with reservoir indicating its release <br>with change in color of urine<br>Expandable and collapsible stent<br>Stents with degradable barbs|Expandable stents for reducing discomfort|-|'''Material'''|Elastically deformable stents<br>Biodegradable polymer based stents<br>Porous polymer for long term implantation<br>Stent with variable hardness|Biodegradable polymers<br>Shape memory alloys<br>General polymer based|-|}
== Inference ==
{|border="2" cellspacing="0" cellpadding=Clinical trials"4" width="82%"|bgcolor ="#538ED5"|<font size =* Boston scientific is conducting clinical "4">'''trialsBoston Scientific''' for '''Truimph Ureteral stent''' which is a ureteral '''stent''' loaded with '''Triclosan''' (used as an antimicrobial agent).The trials are currently in '''Phase II''' in '''canada'''(NCT00250406).</font>|bgcolor ="#538ED5"|<font size ==Patents=== *The unmapped patents are analysed based on the following parameters"4">'''1.Coating on stents:C R BARD''' Boston scientific has patents on Therapeutic</ medicinal coatings on stents which releases into the vascular region. Magnetic nanoparticles which helps in imaging the ureteral stent using MRI. Lubricious coatings which help in easy insertion of the stentfont>|-'''2.Structure of stent:''' Boston scientific has |Relatively late entrant with patents on various structures of stent . For eg: Multiple channels(Depressions) along the length of stent filled filed post mid 90s|Early mover with therapeutic agent,Multiple segments on the distal side of stent which is collapsible to prevent fluid from passing from the bladder to the kidney, Stent with a renal coil with wick portion to prevent reflux of urine,Stent with beads on its surface which is of figure 8 shape having therapeutic agents, Stent with reservoir indicating its release with change patents filed in color of urine,Stents with degradable barbs,Expandable and collapsible stent to reduce patient discomfortmid 80s '''3.Materials used for stent:'''Boston scientific has patents on various materials used for stent. For eg.Elastically deformable stents(polysaccharide|-based hydrogels), Biodegradable polymer based stents, Porous polymer for long term implantation( poly(styrene) blocks and polyisobutylene blocks),Stent with variable hardness (ethylene vinyl acetate and hydroxypropylcellulose)|Increased patent activity since 2000==C.R.Bard==|Patent activity never gained traction|-===Products===* They have '''6 products''' in their ureteral stent portfolio* C.R Bard ureteral stent portfolio have some common features such as:#Most |Large number of the stent has '''Silicone''' as their '''main material'''patents yet to be "productized"#They have stent with '''various''' '''designs''' and shapes eg Figure 4 ureteral stent#Some of the stent have '''coatings''' which is '''liscensed''' from third party eg.|Few patents yet to be "'''pHreecoat'''productized"|-|Some products undergoing clinical trails|No products undergoing clinical trails===Clinical trials===|-There are '''no trials currently''' conducted by C.R.Bard. ===Patents===C R Bard is '''not very active''' |Diverse range of products with variation in filing patents with very '''few''' patents '''filed after 2000'''.material <br>and structure|Small product portfolio*The unmapped patents are analysed based on the following parameters|- '''1.Coating on stent:'''They have a couple of patents related |Seem to therapeutic coatigs on stent surfacebe strengthening they market position '''2.Structure of stent:'''C R. Bard patents are related |Seem to expandable be moving focus away from Ureteral stents for reducing patent discomfortmarket|-'''3.Material used on stent:''' Recent patents focuses on Biodegrable polymers, Shape memory alloys or general polymer based stent|}
= Competitive Landscape =
==IP Activity==
*Patenting activity has been high growth rate during the period 2001 to 2005 with a peak no. of patents in year 2005, followed by saturation during the period 2006 to 2008 and after that a gradual declination upto year 2010 in the ureteral stent research area.
[[Image:IPactivity3.png|thumb|center|1000px|year wise IP activityover the years]]
==Sales ==
Total Sales in 2010 - 4.04 Billion USD
=<span style="color:#C41E3A">Like this report?</span>=
